Issue 22
As the 2024 U.S. election between Donald Trump and Kamala Harris approaches, the biopharma industry is keenly watching how each candidate's policies could shape the future of the…
Issue 21
Hurricane Helene was the second major hurricane of the 2024 Atlantic hurricane season as it hit the southeastern United States just two weeks ago. Sadly, over 200 people…
Issue 20
As 3,000 companies and 60,000 attendees finalize plans before heading to Milan for the 35th anniversary of CPHI, you might have started thinking about what’s on offer and…
Issue 19
Celebrating its 35th year, CPHI Milan is expected to attract more than 62,000 biopharma professionals from all over the world, offering unmatched opportunities to connect with global innovators…
Issue 18
The first pills date back to roughly 1,500 BC, and whilst the pharmaceutical landscape continues to evolve, drug delivery via oral solid dosage (OSD) remains a dominant form…
Issue 17
Recently published reports (from The Brainy Insights & InsightAce Analytic Pvt. Ltd) suggest the CDMO industry is poised for significant growth that will continue into the next decade…
Issue 16
Whilst we’re just past the halfway mark of 2024, mid-year analysis of the top selling drugs for the top 10 pharma companies provides some interesting insights into the…
Issue 15
It’s almost impossible for us to compile an edition of The Pharma Navigator without a major update surrounding GLP-1 drugs. Although it is no secret that drugs are…
Issue 14
A recently published report from Future Market Insights highlights significant potential for global CMO/CDMO market growth; with projections suggesting a significant increase in value from $22.5 bn in…
Issue 13
It wasn’t so very long ago that progress in delivering systemic treatments, via new oral technologies, inhalables, and via a plethora of alternative routes of delivery suggested that…
Issue 12
Did we see you at BIO 2024?If you can’t recall more than a couple of weeks ago, or you were unfortunate to miss out this time around, we’re…
Issue 11
Ask any executive why they think there are drug shortages, and they will no doubt blame some combination of the long-lasting impact of the global pandemic, inflation, energy…
